Zobrazeno 1 - 10
of 56
pro vyhledávání: '"EC50- half maximal effective concentration"'
Autor:
Mahoney, Oneil, Melo, Claudia, Lockhart, Anthony, Cornejal, Nadjet, Alsaidi, Sahar, Wu, Qingli, Simon, Jim, Juliani, Rodolfo, Zydowsky, Thomas M., Priano, Christine, Koroch, Adolfina, Fernández Romero, José A.
Publikováno v:
South African Journal of Botany
Plant-based compounds with antiviral properties against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been identified in Aframomum melegueta through computational models. The seed extract have been traditionally used to treat diff
Publikováno v:
Acta Pharmaceutica Sinica B. 12:1567-1590
HIV reverse transcriptase (RT) inhibitors are the important components of highly active antiretroviral therapies (HAARTs) for anti-HIV treatment and pre-exposure prophylaxis in clinical practice. Many RT inhibitors and their combination regimens have
Publikováno v:
Journal of Advanced Research
Graphical abstract
Introduction Neomenthol, a cyclic monoterpenoid, is a stereoisomer of menthol present in the essential oil of Mentha spp. It is used in food as a flavoring agent, in cosmetics and medicines because of its cooling effects. Howe
Introduction Neomenthol, a cyclic monoterpenoid, is a stereoisomer of menthol present in the essential oil of Mentha spp. It is used in food as a flavoring agent, in cosmetics and medicines because of its cooling effects. Howe
Autor:
Hunter A Hidalgo, Amy Scarborough, Zhen Li, Thomas E. Sharp, David J. Polhemus, J. Stephen Jenkins, Timothy Matsuura, Jeffery D. Schumacher, Daniel P. Kelly, David J. Lefer, Traci T. Goodchild
Publikováno v:
JACC: Basic to Translational Science
Visual Abstract
Highlights • A large animal model that recapitulates the clinical heterogeneity of HFpEF has been developed. • Multiple comorbidities, including obesity, hypercholesterolemia, pre-diabetic phenotype, as well as pulmonary and
Highlights • A large animal model that recapitulates the clinical heterogeneity of HFpEF has been developed. • Multiple comorbidities, including obesity, hypercholesterolemia, pre-diabetic phenotype, as well as pulmonary and
Autor:
Evelyn Seelow, Eberhard Hildt, Denna Tabari, Kathrin Woytinek, David Heiler Martín, Catharina Scholl, Julia C. Stingl, Mira Choi, Benjamin Schmidt, Mirco Glitscher
Publikováno v:
Cellular and Molecular Gastroenterology and Hepatology, Vol 12, Iss 1, Pp 159-180 (2021)
Cellular and Molecular Gastroenterology and Hepatology : CMGH 12, 159-180 (2021). doi:10.1016/j.jcmgh.2021.02.002
Cellular and Molecular Gastroenterology and Hepatology, 12(1):159-180
Cellular and Molecular Gastroenterology and Hepatology
Cellular and Molecular Gastroenterology and Hepatology : CMGH 12, 159-180 (2021). doi:10.1016/j.jcmgh.2021.02.002
Cellular and Molecular Gastroenterology and Hepatology, 12(1):159-180
Cellular and Molecular Gastroenterology and Hepatology
Background and aims The Hepatitis E virus hijacks the endosomal system for its release. These structures are highly dependent on cholesterol. Hence, this study investigates the impact of HEV on cholesterol-metabolism, the effect of intracellular chol
Publikováno v:
Computational and Structural Biotechnology Journal, Vol 19, Iss, Pp 4684-4701 (2021)
Computational and Structural Biotechnology Journal
Computational and Structural Biotechnology Journal
Graphical abstract
Safer and more-effective drugs are urgently needed to counter infections with the highly pathogenic SARS-CoV-2, cause of the COVID-19 pandemic. Identification of efficient inhibitors to treat and prevent SARS-CoV-2 infection i
Safer and more-effective drugs are urgently needed to counter infections with the highly pathogenic SARS-CoV-2, cause of the COVID-19 pandemic. Identification of efficient inhibitors to treat and prevent SARS-CoV-2 infection i
Autor:
Adenike Bernice-Eloise Adeoye, Joshua Iseoluwa Orege, Lanre Anthony Gbadegesin, Emmanuel Ayodeji Ayeni, Bashir Bolaji Tiamiyu, Yusuf Ajibola Ibrahim, Happiness Ijeoma Umeobi, Toluwanimi Oluwadara Akinyemi, S. B. Adeyemi, Mercy Adaramodu Oluwatoyosi, Joshua Adedeji Bolarin, Chuks Kenneth Odoh
Publikováno v:
International Immunopharmacology
Highlights • Therapeutic drugs with plausible efficacy against COVID-19 have been reviewed. • Notable drugs, antiviral compounds and natural products against COVID-19 were discussed. • Different drug administration regimens were appraised to as
Autor:
Gordana Wozniak-Knopp, Gerhard Stadlmayr, Florian Rüker, Filippo Benedetti, Katharina Stadlbauer, Florian Stracke
Publikováno v:
Biochemistry and Biophysics Reports, Vol 26, Iss, Pp 100959-(2021)
Biochemistry and Biophysics Reports
Biochemistry and Biophysics Reports
Monoclonal antibodies can acquire the property of engagement of a second antigen via fusion methods or modification of their CDR loops, but also by modification of their constant domains, such as in the mAb2 format where a set of mutated amino acid r
Autor:
Feihu Yan, Ying Guo, Logan Banadyga, Shihua He, Wenjun Zhu, Guo Jiamei, Xiangguo Qiu, Qing Chen, Tang Ke, Xiaoyu Zhang
Publikováno v:
Antiviral Research
Lassa virus (LASV) causes Lassa hemorrhagic fever in humans and poses a significant threat to public health in West Africa. Current therapeutic treatments for Lassa fever are limited, making the development of novel countermeasures an urgent priority
Autor:
Shiraki, Kimiyasu, Sato, Noriaki, Sakai, Kaoru, Matsumoto, Shirou, Kaszynski, Richard H., Takemoto, Masaya
Publikováno v:
Pharmacology & Therapeutics
Favipiravir, a broad-spectrum RNA-dependent RNA polymerase inhibitor, inhibits the replication of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) at significantly lower concentrations than the plasma trough levels achieved by the dosage